generating gross proceeds of $8,000,000. On November 15, 2021, the underwriters exercised their overallotment option to purchase 3,000,000 units, at a price of $10.00 per unit, generating gross proceeds of $30,000,000. Also on November 15, 2021, we consummated an additional sale of 900,000 private placement warrants to Sponsor at a price of $1.00 per warrant, generating gross proceeds of $900,000.
Following its initial public offering and the sale of the private placement warrants, a total of $232,300,000 was placed in the trust account. We incurred $21,834,402 in transaction costs, including $4,600,000 of underwriting fees, $8,050,000 of deferred underwriting fees and $9,184,402 of other costs. Effective as of November 3, 2022, the underwriters from the Company’s initial public offering resigned and withdrew from their role in the Business Combination and thereby waived their entitlement to the deferred underwriting fees of $8,050,000, which the Company has recorded as a gain on settlement of underwriter fees on the statements of shareholders’ deficit for the year ended December 31, 2022 for $7,847,542, which represents the original amount recorded to accumulated deficit, and the remaining balance of $202,548 representing the amount recorded to the statements of operations for the year ended December 31, 2022.
For the period ended December 31, 2021, cash used in operating activities was $839,514. Net loss of $2,633,699 was offset by changes in operating assets and liabilities, which used $603,036 of cash.
For the period ended December 31, 2022, cash used in operating activities was $446,617. Net income was $9,759,713 and changes in operating assets and liabilities generated $4,017,290 of cash, which were offset by $14,223,620 in non-cash adjustments to reconcile net income to net cash used in operations, including an unrealized gain on marketable securities held in the trust account of $2,395,202, a gain on settlement of underwriting fees of $202,458, and a gain from the change in fair value of derivative warrant liabilities of $11,625,960.
For the six months ended June 30, 2023, cash provided in operating activities was $67,155. For the six months ended June 30, 2023, net income of $500,925 was offset by general and administrative expenses paid by related party of $78,413, interest earned on investment held in trust account of $4,080,757, changes in fair value of derivative warrant liabilities of $167,280, and changes in operating assets and liabilities, which generated $3,735,854 of cash.
For the six months ended June 30, 2022, cash used in operating activities was $364,764. Net income of $9,974,146 was offset by general and administrative expenses paid by related party of $6,499, interest earned on investment held in the trust account of $164,227, changes in fair value of derivative warrant liabilities of $10,467,240, and changes in operating assets and liabilities, which used $299,056 of cash.
As of June 30, 2023, we had cash and marketable securities held in the trust account of $49,362,200. In connection with the vote to approve the First Extension Amendment, holders of 18,281,946 Class A ordinary shares exercised their right to redeem their shares for cash at a redemption price of approximately $10.36 per share, for an aggregate redemption amount of $189,434,603. As a result, 4,718,054 Class A ordinary shares remain outstanding. As of , 2023, funds in the trust account totaled approximately $ and were held in U.S. treasury securities. We may withdraw interest to pay our income taxes, if any. We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account (which interest shall be net of taxes payable) to complete our business combination. To the extent that our share capital is used, in whole or in part, as consideration to complete a business combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of June 30, 2023, we had cash of $41,844. We intend to use the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a business combination.
193